Does a standardized pulmonary vein isolation workflow aiming for contiguous lesions improve 12-month freedom from arrhythmias in patients with paroxysmal atrial fibrillation?
A standardized pulmonary vein isolation workflow aiming for contiguous lesions achieves high acute success and approximately 80% freedom from arrhythmias at 12 months in patients with paroxysmal atrial fibrillation.
The VISTAX trial demonstrated that a standardized PAF ablation workflow aiming for contiguous lesions leads to low rates of PAEs, high acute first-pass isolation rates, and 12-month freedom from arrhythmias approaching 80%. Further research is needed to improve the reproducibility of the outcomes across a wider range of centres.Clinical trial registration: ClinicalTrials.gov, number NCT03062046, https://clinicaltrials.gov/ct2/show/NCT03062046.
Duytschaever et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: